Harm Reduction Training Institute Course List

Course Catalog

CourseList Face to Face CourseList Online Training CourseList Webinar   CourseList   Clear Search
click header arrows to sort
Name
Face To Face New Course Substance Use 101

This one-day training will review basic information about substance use with a focus on why people use substances, common drugs people use, how these impact a person and harm reduction and drug treatment options.  The training will provide an overview of commonly used drugs (Cocaine/crack, heroin, marijuana, K2, MDMA, methamphetamine, etc.) and explain what they look like, cost, how they affect the brain, and risk factors for health.  Participants will learn how tolerance and routes of administration impact the effects of drugs.  Participants will learn how to use Harm Reduction methods to engage with people who use drugs and better understand their experience.

By the end of the training, workshop participants will be able to:

  1. Use a Harm Reduction framework to identify risks and develop strategies for engaging PWUD in care, retaining PWUD in care, and for reduction drug related harms
  2. Understand how tolerance, route of administration, and Drug, Set, and Setting impact the way drugs effect people who use drugs
  3. Describe the effects of drugs to service providers and PWUD
  4. Understand the continuum of drug use and how stigma, race, socioeconomic status, gender identity impact both people’s vulnerability to and capacity for effectively dealing with drug-related harm
  5. Describe the drug treatment landscape in NYS as well as the requirements, benefits, and deficits of different types of treatments

 

Prerequisite: none

 

Audience: All health and human service providers, including peer workers, who work with people who use drugs

This one-day training will review basic information about substance use with a focus on why people use substances, common drugs people use, how these impact a person and harm reduction and drug treatment options.  The training will provide an overview of commonly used drugs (Cocaine/crack, heroin, marijuana, K2, MDMA, methamphetamine, etc.) and explain what they look like, cost, how they affect the brain, and risk factors for health.  Participants will learn how tolerance and routes of administration impact the effects of drugs.  Participants will learn how to use Harm Reduction methods to engage with people who use drugs and better understand their experience.

By the end of the training, workshop participants will be able to:

  1. Use a Harm Reduction framework to identify risks and develop strategies for engaging PWUD in care, retaining PWUD in care, and for reduction drug related harms
  2. Understand how tolerance, route of administration, and Drug, Set, and Setting impact the way drugs effect people who use drugs
  3. Describe the effects of drugs to service providers and PWUD
  4. Understand the continuum of drug use and how stigma, race, socioeconomic status, gender identity impact both people’s vulnerability to and capacity for effectively dealing with drug-related harm
  5. Describe the drug treatment landscape in NYS as well as the requirements, benefits, and deficits of different types of treatments

 

Prerequisite: none

 

Audience: All health and human service providers, including peer workers, who work with people who use drugs

Face To Face Hepatitis C Prevention with Young People Who Inject Drugs (PWID)

This one-day training will explore Hepatitis C virus (HCV) prevention for young (18-29 years) people who inject drugs (PWID) in both urban and non-urban settings. The training will emphasize the link between viral hepatitis infection, prescription opioid misuse, and the potential for transition to heroin. Through interactive skills building activities, participants will identify strategies for effective and culturally competent engagement and intervention with youth who inject drugs.

As a result of this training, participants will be able to:

  • Describe the scope of HCV infection in young PWIDs;
  • Explain the association between the emerging epidemic of HCV infections among young persons and the prescription drug epidemic;
  • Identify factors impacting young PWIDs’ vulnerability to HCV infection;
  • Identify the principles of youth-centered, harm reduction-oriented service provision;
  • Formulate effective prevention messages that address young PWIDs’ risk behaviors related to drug use; and
  • Identify strategies for HCV prevention, care and treatment for young PWID.

Audience: All health and human service providers and Peer Workers. 

Prerequisite: Although there is no prerequisite for this course, it is strongly recommended that participants have previous knowledge or basic training on HIV, hepatitis C and substance use.

Associated Materials:

Blood to Blood - Hepatitis C Drug Use- Tattoos/Body Piercing

http://www.health.ny.gov/publications/1803.pdf

http://www.health.ny.gov/publications/1804.pdf

What Does Your Needle Look Like?

http://www.health.ny.gov/publications/9608.pdf

http://www.health.ny.gov/publications/9509.pdf

Hepatitis C: Know the Facts Scratcher Cards

http://www.health.ny.gov/publications/1855.pdf

http://www.health.ny.gov/publications/1856.pdf

This training is provided under New York State Office of Alcoholism and Substance Abuse Services (OASAS) Education and Training Provider Certification Number 0305. Under the NYS OASAS Provider Certificate, this training is approved for 6.5 clock hours toward the education and training requirements for renewal of CASAC/CPP/CPS certification. 

This one-day training will explore Hepatitis C virus (HCV) prevention for young (18-29 years) people who inject drugs (PWID) in both urban and non-urban settings. The training will emphasize the link between viral hepatitis infection, prescription opioid misuse, and the potential for transition to heroin. Through interactive skills building activities, participants will identify strategies for effective and culturally competent engagement and intervention with youth who inject drugs.

As a result of this training, participants will be able to:

  • Describe the scope of HCV infection in young PWIDs;
  • Explain the association between the emerging epidemic of HCV infections among young persons and the prescription drug epidemic;
  • Identify factors impacting young PWIDs’ vulnerability to HCV infection;
  • Identify the principles of youth-centered, harm reduction-oriented service provision;
  • Formulate effective prevention messages that address young PWIDs’ risk behaviors related to drug use; and
  • Identify strategies for HCV prevention, care and treatment for young PWID.

Audience: All health and human service providers and Peer Workers. 

Prerequisite: Although there is no prerequisite for this course, it is strongly recommended that participants have previous knowledge or basic training on HIV, hepatitis C and substance use.

Associated Materials:

Blood to Blood - Hepatitis C Drug Use- Tattoos/Body Piercing

http://www.health.ny.gov/publications/1803.pdf

http://www.health.ny.gov/publications/1804.pdf

What Does Your Needle Look Like?

http://www.health.ny.gov/publications/9608.pdf

http://www.health.ny.gov/publications/9509.pdf

Hepatitis C: Know the Facts Scratcher Cards

http://www.health.ny.gov/publications/1855.pdf

http://www.health.ny.gov/publications/1856.pdf

This training is provided under New York State Office of Alcoholism and Substance Abuse Services (OASAS) Education and Training Provider Certification Number 0305. Under the NYS OASAS Provider Certificate, this training is approved for 6.5 clock hours toward the education and training requirements for renewal of CASAC/CPP/CPS certification. 

Online Training Harm Reduction Approach Overview Webinar - Archive

This two-hour archived webinar will provide participants with an introduction to basic philosophy and practices of HIV/STI/HCV harm reduction with regards to substance use and sexual risk behavior.  The webinar will provide an opportunity to reflect on your values and attitudes regarding harm reduction, as well as learn specific harm reduction strategies.

As a result of this training, participants will be able to:

  1. Define harm reduction as it is used in HIV/STI/HCV prevention;
  2. List at least three elements of the harm reduction model;
  3. Identify at least three attitudes they have about using a harm reduction approach;
  4. Identify at least three examples of harm reduction options for substance use behaviors and sexual behaviors;
  5. Identify negotiated safety techniques for injection risk reduction and sexual risk reduction

Prerequisite: None

Audience: All non-physician health and human services providers; peer educators; and anyone in the general public with an interest in HIV/AIDS.

This two-hour archived webinar will provide participants with an introduction to basic philosophy and practices of HIV/STI/HCV harm reduction with regards to substance use and sexual risk behavior.  The webinar will provide an opportunity to reflect on your values and attitudes regarding harm reduction, as well as learn specific harm reduction strategies.

As a result of this training, participants will be able to:

  1. Define harm reduction as it is used in HIV/STI/HCV prevention;
  2. List at least three elements of the harm reduction model;
  3. Identify at least three attitudes they have about using a harm reduction approach;
  4. Identify at least three examples of harm reduction options for substance use behaviors and sexual behaviors;
  5. Identify negotiated safety techniques for injection risk reduction and sexual risk reduction

Prerequisite: None

Audience: All non-physician health and human services providers; peer educators; and anyone in the general public with an interest in HIV/AIDS.

Online Training Hepatitis C Basics - Archive

This 2 -hour archived webinar will provide basic information about Hepatitis C (HCV) for health and human service providers.  This webinar can serve as an introductory course for anyone with a professional or personal interest in Hepatitis C.  

 Objectives: By the end of this webinar, participants will be able to:

  • Describe the basics of how HCV can be transmitted;
  • Describe how HCV progresses and the importance of care and treatment;
  • List the steps to identify HCV infection;
  • Discuss basic HCV prevention strategies;
  • Describe  basic tips for taking care of the liver and living healthy while living with HCV

Prerequisite: none

Audience: All health and human service providers, including Peers Workers  

This 2 -hour archived webinar will provide basic information about Hepatitis C (HCV) for health and human service providers.  This webinar can serve as an introductory course for anyone with a professional or personal interest in Hepatitis C.  

 Objectives: By the end of this webinar, participants will be able to:

  • Describe the basics of how HCV can be transmitted;
  • Describe how HCV progresses and the importance of care and treatment;
  • List the steps to identify HCV infection;
  • Discuss basic HCV prevention strategies;
  • Describe  basic tips for taking care of the liver and living healthy while living with HCV

Prerequisite: none

Audience: All health and human service providers, including Peers Workers  

Online Training Talking with Clients about Hepatitis C Treatment - Archive

This 2 -hour archived webinar will describe the role of non-clinical health and human services providers in supporting clients living with chronic Hepatitis C as they consider starting hepatitis C treatment. Participants will become familiar with current guidelines regarding populations prioritized for treatment, issues relating to treatment access, and patient assistance resources.

 Objectives: By the end of this session participants will be able to:

  • Describe the recent progress in treatment options for patients living with hepatitis C (shorter duration, fewer side effects, better health outcomes)
  • Describe the importance of engaging in primary care, regardless of the clients intent to undergo treatment
  • Identify strategies to support clients as they prepare for and engage in HCV treatment
  • Define sustained virologic response (SVR)
  • Discuss strategies to address the risk of reinfection with clients who achieve SVR

Prerequisite: Although there is no prerequisite for this course, it is strongly recommended participants have some knowledge or basic training on hepatitis C.

Audience: All health and human service providers.

This 2 -hour archived webinar will describe the role of non-clinical health and human services providers in supporting clients living with chronic Hepatitis C as they consider starting hepatitis C treatment. Participants will become familiar with current guidelines regarding populations prioritized for treatment, issues relating to treatment access, and patient assistance resources.

 Objectives: By the end of this session participants will be able to:

  • Describe the recent progress in treatment options for patients living with hepatitis C (shorter duration, fewer side effects, better health outcomes)
  • Describe the importance of engaging in primary care, regardless of the clients intent to undergo treatment
  • Identify strategies to support clients as they prepare for and engage in HCV treatment
  • Define sustained virologic response (SVR)
  • Discuss strategies to address the risk of reinfection with clients who achieve SVR

Prerequisite: Although there is no prerequisite for this course, it is strongly recommended participants have some knowledge or basic training on hepatitis C.

Audience: All health and human service providers.

Online Training Naloxone Dispensing in Pharmacies and the Naloxone Copayment Assistance Program- ARCHIVE

New York State has replaced the replaced the Amphastar generic product with the Adapt Narcan® single step formulation as part of the Opioid Overdose Initiative. NYSDOH has created the Naloxone Co-payment Assistance Program (N-CAP). Individuals with prescription coverage as part of their health insurance plan can access naloxone at their local pharmacy and N-CAP will cover co-payments in an amount up to $40. Each prescription dispensed will be billed to N-CAP, not to the individual getting naloxone. This will apply to prescriptions written for an individual and those obtained under standing orders. 

By the end of this archived webinar, participants will be able to:

  1. Instruct people on the use of the new Adapt Narcan formulation
  2. Describe naloxone standing orders in pharmacies for naloxone
  3. Explain how the Naloxone Co-pay Assistance Program (N-CAP) works. 

New York State has replaced the replaced the Amphastar generic product with the Adapt Narcan® single step formulation as part of the Opioid Overdose Initiative. NYSDOH has created the Naloxone Co-payment Assistance Program (N-CAP). Individuals with prescription coverage as part of their health insurance plan can access naloxone at their local pharmacy and N-CAP will cover co-payments in an amount up to $40. Each prescription dispensed will be billed to N-CAP, not to the individual getting naloxone. This will apply to prescriptions written for an individual and those obtained under standing orders. 

By the end of this archived webinar, participants will be able to:

  1. Instruct people on the use of the new Adapt Narcan formulation
  2. Describe naloxone standing orders in pharmacies for naloxone
  3. Explain how the Naloxone Co-pay Assistance Program (N-CAP) works. 
Online Training What’s the Scoop on Fentanyl? - Archive

This pre-recorded webinar will discuss Fentanyl as a potent, synthetic opioid pain medication that has been associated with the recent surge in opioid related overdose deaths. This 2-hour webinar will provide an overview of fentanyl as a medication and as a contaminant in the illicit drug supply. The role of fentanyl in the current wave of overdose deaths, how to recognize a fentanyl related overdose and harm reduction responses will be discussed.

By the end of this webinar, participants will be able to:

  •         Recall trends in fentanyl-related drug user deaths;
  •         Describe the pharmacology of fentanyl and its analogs;
  •         Discuss fentanyl from the perspective of drug users;
  •         Explain how to recognize and respond to a fentanyl related overdose; and
  •         Identify harm reduction practices that drug users can follow to protect themselves against overdose.

This pre-recorded webinar will discuss Fentanyl as a potent, synthetic opioid pain medication that has been associated with the recent surge in opioid related overdose deaths. This 2-hour webinar will provide an overview of fentanyl as a medication and as a contaminant in the illicit drug supply. The role of fentanyl in the current wave of overdose deaths, how to recognize a fentanyl related overdose and harm reduction responses will be discussed.

By the end of this webinar, participants will be able to:

  •         Recall trends in fentanyl-related drug user deaths;
  •         Describe the pharmacology of fentanyl and its analogs;
  •         Discuss fentanyl from the perspective of drug users;
  •         Explain how to recognize and respond to a fentanyl related overdose; and
  •         Identify harm reduction practices that drug users can follow to protect themselves against overdose.